Robert Thomas Freeman $ALHC SEC Form 4 Insider Trading

Robert Thomas Freeman has filed a total of 44 insider trades in $ALHC since 2021. Their most recent trade was a sale of 208 shares, made on Mar 12, 2025. Their largest trade was a sale of 250,000 shares, made on Mar 04, 2025. We estimate that they now own 1.5 million shares of $ALHC, worth an estimated $23.4 million.

Insider Trading at $ALHC

There have been a total of 230 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 51.1 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 5,238 shares reported by Robert L. Scavo (Chief Information Officer), made on Mar 12, 2025.

$ALHC Executives and Stock Owners with Insider Trades

• Robert Thomas Freeman, Chief Financial Officer

• John E Kao, Chief Executive Officer

• Dawn Christine Maroney, President, Markets

• Dinesh M. Kumar, Chief Med & Operating Officer

• Christopher J Joyce, Chief Legal and Admin. Officer

• Hakan Kardes, Chief Experience Officer

• Hyong Kim, Chief Medical Officer

• Robert L. Scavo, Chief Information Officer

• Dawn Christine Maroney, President

• Dinesh M. Kumar, Chief Medical Officer

• Joseph S Konowiecki, Chairman of the Board

• Richard A. Cross, SVP, General Counsel

• Donald Steven Furman, Chief Clinical Officer

• Andreas P. Wagner, Chief Human Resources Officer

• Rajesh Shrestha, Pres., New Markets & CBO

• Sebastian Burzacchi, COO - Mgmt Services Org

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.